UCP1 and Insulin resistance: Systemic administration of synthesized IMD reduced high-fat diet-induced body weight gain, as well as systemic insulin resistance, through activation of the AMP-activated protein kinase (AMPK) pathway and an increase of uncoupling protein 1 (UCP1) expression in adipose tissue (Zhang et al., 2016).